{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:13:49Z","timestamp":1790082829904,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T00:00:00Z","timestamp":1297296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Despite the known multi-factorial nature of atrophic fracture non-unions, a possible genetic predisposition for the development of this complication after long bone fractures remains unknown. This pilot study aimed to address this issue by performing a preliminary SNP analysis of specific genes known to regulate fracture healing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of fifteen SNPs within four genes of the Bone Morphogenetic Protein (BMP) pathway (<jats:italic>BMP-2, BMP-7<\/jats:italic>, <jats:italic>NOGGIN<\/jats:italic> and <jats:italic>SMAD6<\/jats:italic>) were examined, in 109 randomly selected patients with long bone fractures as a result of motor vehicle accident, fall or direct blow. There were sixty-two patients with atrophic non-union and forty-seven patients (54 fractures) with uneventful fracture union. Overall SNPs frequencies were computed with respect to patient's age, gender, smoking habits, fracture-associated parameters and the use of nonsteroidal anti-inflammatory drugs (NSAIDs), and tested for their association to the impaired bone healing process, using binary logistic regression (STATA 11.1; StataCorp, Texas USA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Statistical analysis revealed age to be an important covariate in the development of atrophic non-union (<jats:italic>p<\/jats:italic> = 0.01, OR 1.05 [per year]), and two specific genotypes (G\/G genotype of the rs1372857 SNP, located on <jats:italic>NOGGIN<\/jats:italic> and T\/T genotype of the rs2053423 SNP, located on <jats:italic>SMAD6<\/jats:italic>) to be associated with a greater risk of fracture non-union (<jats:italic>p<\/jats:italic> = 0.02, OR 4.56 and <jats:italic>p<\/jats:italic> = 0.04, OR 10.27, respectively, after adjustment for age).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This is the first clinical study to investigate the potential existence of genetic susceptibility to fracture non-union. Even though no concrete conclusions can be obtained from this pilot study, our results indicate the existence of a potential genetically predetermined impairment within the BMP signalling cascade, initiated after a fracture and when combined with other risk factors could synergistically increase the susceptibility of a patient to develop non-union. Further research is desirable in order to clarify the genetic component and its role and interaction with other risk factors in the development of atrophic long bone non-union, as simple genetic testing may contribute to the early identification of patients at risk in the future and the on-time intervention at the biologic aspects of bone healing.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2474-12-44","type":"journal-article","created":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T13:12:54Z","timestamp":1297343574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Genetic predisposition to fracture non-union: a case control study of a preliminary single nucleotide polymorphisms analysis of the BMP pathway"],"prefix":"10.1186","volume":"12","author":[{"given":"Rozalia","family":"Dimitriou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander F","family":"Markham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V","family":"Giannoudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,10]]},"reference":[{"key":"1078_CR1","first-page":"85","volume-title":"American Academy of Orthopaedic Surgeons. Musculoskeletal conditions in the United States","author":"A Praemer","year":"1992","unstructured":"Praemer A, Furner S, Rice DP: From Musculoskeletal injuries. American Academy of Orthopaedic Surgeons. Musculoskeletal conditions in the United States. 1992, Park Ridge, IL, USA, 85-124."},{"key":"1078_CR2","first-page":"507","volume-title":"Skeletal Trauma Basic science management and reconstruction","author":"MR Brinker","year":"2003","unstructured":"Brinker MR: From Nonunions: evaluation and treatment. Skeletal Trauma Basic science management and reconstruction. Edited by: Browner BD, Jupiter JB, Levine AM, Trafton PG. 2003, Philadelphia: Saunders, 507-604. 3","edition":"3"},{"issue":"5","key":"1078_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1302\/0301-620X.82B5.9899","volume":"82","author":"PV Giannoudis","year":"2000","unstructured":"Giannoudis PV, MacDonald DA, Matthews SJ, Smith RM, Furlong AJ, De Boer P: Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg Br. 2000, 82 (5): 655-658. 10.1302\/0301-620X.82B5.9899.","journal-title":"J Bone Joint Surg Br"},{"issue":"4","key":"1078_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1053\/gast.2002.32415","volume":"122","author":"AP Cuthbert","year":"2002","unstructured":"Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, Mascheretti S, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG: The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 2002, 122 (4): 867-874. 10.1053\/gast.2002.32415.","journal-title":"Gastroenterology"},{"issue":"4","key":"1078_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/01.HYP.0000013703.07316.7F","volume":"39","author":"ME Hyndman","year":"2002","unstructured":"Hyndman ME, Parsons HG, Verma S, Bridge PJ, Edworthy S, Jones C, Lonn E, Charbonneau F, Anderson TJ: The T-786-- > C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension. 2002, 39 (4): 919-922. 10.1161\/01.HYP.0000013703.07316.7F.","journal-title":"Hypertension"},{"issue":"1","key":"1078_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0378-1119(94)00448-2","volume":"159","author":"H Raunio","year":"1995","unstructured":"Raunio H, Husgafvel-Pursiainen K, Anttila S, Hietanen E, Hirvonen A, Pelkonen O: Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review. Gene. 1995, 159 (1): 113-121. 10.1016\/0378-1119(94)00448-2.","journal-title":"Gene"},{"issue":"2","key":"1078_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1017\/S002966510700540X","volume":"66","author":"SH Ralston","year":"2007","unstructured":"Ralston SH: Genetics of osteoporosis. Proc Nutr Soc. 2007, 66 (2): 158-165. 10.1017\/S002966510700540X.","journal-title":"Proc Nutr Soc"},{"issue":"2","key":"1078_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.brainresrev.2006.04.001","volume":"52","author":"S Akbarian","year":"2006","unstructured":"Akbarian S, Huang HS: Molecular and cellular mechanisms of altered GAD1\/GAD67 expression in schizophrenia and related disorders. Brain Res Rev. 2006, 52 (2): 293-304. 10.1016\/j.brainresrev.2006.04.001.","journal-title":"Brain Res Rev"},{"issue":"1","key":"1078_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jhg.2008.6","volume":"54","author":"Y Nakamura","year":"2009","unstructured":"Nakamura Y: DNA variations in human and medical genetics: 25 years of my experience. J Hum Genet. 2009, 54 (1): 1-8. 10.1038\/jhg.2008.6.","journal-title":"J Hum Genet"},{"issue":"12","key":"1078_CR10","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.injury.2005.07.019","volume":"36","author":"R Dimitriou","year":"2005","unstructured":"Dimitriou R, Tsiridis E, Giannoudis PV: Current concepts of molecular aspects of bone healing. Injury. 2005, 36 (12): 1392-1404. 10.1016\/j.injury.2005.07.019.","journal-title":"Injury"},{"issue":"1-2","key":"1078_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11154-006-9000-6","volume":"7","author":"E Gazzerro","year":"2006","unstructured":"Gazzerro E, Canalis E: Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord. 2006, 7 (1-2): 51-65. 10.1007\/s11154-006-9000-6.","journal-title":"Rev Endocr Metab Disord"},{"key":"1078_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S8756-3282(96)00259-1","volume":"19","author":"H Yamashita","year":"1996","unstructured":"Yamashita H, Ten Dijke P, Heldin CH, Miyazono K: Bone morphogenetic protein receptors. Bone. 1996, 19: 569-574. 10.1016\/S8756-3282(96)00259-1.","journal-title":"Bone"},{"key":"1078_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S8756-3282(99)00113-1","volume":"25","author":"K Miyazono","year":"1999","unstructured":"Miyazono K: Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone. 1999, 25: 91-93. 10.1016\/S8756-3282(99)00113-1.","journal-title":"Bone"},{"issue":"Suppl 1","key":"1078_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.injury.2006.02.039","volume":"37","author":"R Dimitriou","year":"2006","unstructured":"Dimitriou R, Tsiridis E, Carr I, Simpson H, Giannoudis PV: The role of inhibitory molecules in fracture healing. Injury. 2006, 37 (Suppl 1): 20-29. 10.1016\/j.injury.2006.02.039.","journal-title":"Injury"},{"issue":"4","key":"1078_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1359\/jbmr.2000.15.4.663","volume":"15","author":"E Abe","year":"2000","unstructured":"Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, Economides AN, Stahl N, Jilka RL, Manolagas SC: Essential requirement of BMPs-2\/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res. 2000, 15 (4): 663-673. 10.1359\/jbmr.2000.15.4.663.","journal-title":"J Bone Miner Res"},{"key":"1078_CR16","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1242\/dev.122.10.2977","volume":"122","author":"H Zhang","year":"1996","unstructured":"Zhang H, Bradley A: Mice deficient for BMP2 are nonviable and have defects in amnion\/chorion and cardiac development. Development. 1996, 122: 2977-2986.","journal-title":"Development"},{"issue":"12","key":"1078_CR17","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/ng1916","volume":"38","author":"K Tsuji","year":"2006","unstructured":"Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ, Rosen V: BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet. 2006, 38 (12): 1424-1429. 10.1038\/ng1916.","journal-title":"Nat Genet"},{"issue":"22","key":"1078_CR18","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1101\/gad.9.22.2808","volume":"9","author":"G Luo","year":"1995","unstructured":"Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G: BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 1995, 9 (22): 2808-2820. 10.1101\/gad.9.22.2808.","journal-title":"Genes Dev"},{"issue":"1","key":"1078_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/excr.1996.3411","volume":"230","author":"N Jena","year":"1997","unstructured":"Jena N, Mart\u00edn-Seisdedos C, McCue P, Croce CM: BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. Exp Cell Res. 1997, 230 (1): 28-37. 10.1006\/excr.1996.3411.","journal-title":"Exp Cell Res"},{"issue":"6","key":"1078_CR20","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/art.22701","volume":"56","author":"N Shintani","year":"2007","unstructured":"Shintani N, Hunziker EB: Chondrogenic differentiation of bovine synovium: bone morphogenetic proteins 2 and 7 and transforming growth factor beta1 induce the formation of different types of cartilaginous tissue. Arthritis Rheum. 2007, 56 (6): 1869-1879. 10.1002\/art.22701.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1078_CR21","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1210\/en.2002-220918","volume":"144","author":"RD Devlin","year":"2003","unstructured":"Devlin RD, Du Z, Pereira RC, Kimble RB, Economides AN, Jorgetti V, Canalis E: Skeletal overexpression of noggin results in osteopenia and reduced Bone formation. Endocrinology. 2003, 144 (5): 1972-1978. 10.1210\/en.2002-220918.","journal-title":"Endocrinology"},{"issue":"6","key":"1078_CR22","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1172\/JCI15543","volume":"112","author":"XB Wu","year":"2003","unstructured":"Wu XB, Li Y, Schneider A, Yu W, Rajendren G, Iqbal J, Yamamoto M, Alam M, Brunet LJ, Blair HC, Zaidi M, Abe E: Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest. 2003, 112 (6): 924-934.","journal-title":"J Clin Invest"},{"issue":"3","key":"1078_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1359\/jbmr.2001.16.3.497","volume":"16","author":"P Aspenberg","year":"2001","unstructured":"Aspenberg P, Jeppsson C, Economides AN: The Bone morphogenetic proteins antagonist noggin inhibits membranous ossification. J Bone Miner Res. 2001, 16 (3): 497-500. 10.1359\/jbmr.2001.16.3.497.","journal-title":"J Bone Miner Res"},{"key":"1078_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1083\/jcb.200311015","volume":"165","author":"M Horiki","year":"2004","unstructured":"Horiki M, Imamura T, Okamoto M, Hayashi M, Murai J, Myoui A, Ochi T, Miyazono K, Yoshikawa H, Tsumaki N: Smad6\/Smurf1 overexpression in cartilage delays chondrocytes hypertrophy and causes dwarfism with osteopenia. J Cell Biol. 2004, 165: 433-445. 10.1083\/jcb.200311015.","journal-title":"J Cell Biol"},{"issue":"2","key":"1078_CR25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gr.4346306","volume":"169","author":"E Setakis","year":"2006","unstructured":"Setakis E, Stirnadel H, Balding DJ: Logistic regression protects against population structure in genetic association studies. Genome Res. 2006, 169 (2): 290-226.","journal-title":"Genome Res"},{"issue":"7247","key":"1078_CR26","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1136\/bmj.320.7247.1468","volume":"320","author":"JM Bland","year":"2000","unstructured":"Bland JM, Altman DG: Statistics notes. The odds ratio. BMJ. 2000, 320 (7247): 1468-10.1136\/bmj.320.7247.1468.","journal-title":"BMJ"},{"issue":"6","key":"1078_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00223-008-9144-3","volume":"82","author":"MB Manigrasso","year":"2008","unstructured":"Manigrasso MB, O'Connor JP: Comparison of fracture healing among different inbred mouse strains. Calcif Tissue Int. 2008, 82 (6): 465-474. 10.1007\/s00223-008-9144-3.","journal-title":"Calcif Tissue Int"},{"issue":"6-7","key":"1078_CR28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s00335-007-9017-5","volume":"18","author":"KJ Jepsen","year":"2007","unstructured":"Jepsen KJ, Hu B, Tommasini SM, Courtland HW, Price C, Terranova CJ, Nadeau JH: Genetic randomization reveals functional relationships among morphologic and tissue-quality traits that contribute to bone strength and fragility. Mamm Genome. 2007, 18 (6-7): 492-507. 10.1007\/s00335-007-9017-5.","journal-title":"Mamm Genome"},{"issue":"5","key":"1078_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/00125817-200109000-00004","volume":"3","author":"ME Dixon","year":"2001","unstructured":"Dixon ME, Armstrong P, Stevens DB, Bamshad M: Identical mutations in NOG can cause either tarsal\/carpal coalition syndrome or proximal symphalangism. Genet Med. 2001, 3 (5): 349-353. 10.1097\/00125817-200109000-00004.","journal-title":"Genet Med"},{"issue":"2","key":"1078_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1086\/519697","volume":"81","author":"K Lehmann","year":"2007","unstructured":"Lehmann K, Seemann P, Silan F, Goecke TO, Irgang S, Kjaer KW, Kjaergaard S, Mahoney MJ, Morlot S, Reissner C, Kerr B, Wilkie AO, Mundlos S: A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. Am J Hum Genet. 2007, 81 (2): 388-396. 10.1086\/519697.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1078_CR31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/ajmg.1504","volume":"102","author":"O S\u00e9monin","year":"2001","unstructured":"S\u00e9monin O, Fontaine K, Daviaud C, Ayuso C, Lucotte G: Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am J Med Genet. 2001, 102 (4): 314-317.","journal-title":"Am J Med Genet"},{"issue":"5","key":"1078_CR32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS: A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressive. Nat Genet. 2006, 38 (5): 525-527. 10.1038\/ng1783.","journal-title":"Nat Genet"},{"issue":"5368","key":"1078_CR33","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1126\/science.280.5368.1455","volume":"280","author":"LJ Brunet","year":"1998","unstructured":"Brunet LJ, McMahon JA, McMahon AP, Harland RM: Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science. 1998, 280 (5368): 1455-1457. 10.1126\/science.280.5368.1455.","journal-title":"Science"},{"issue":"5","key":"1078_CR34","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.bone.2007.01.001","volume":"40","author":"CM Edgar","year":"2007","unstructured":"Edgar CM, Chakravarthy V, Barnes G, Kakar S, Gerstenfeld LC, Einhorn TA: Autogenous regulation of a network of bone morphogenetic proteins (BMPs) mediates the osteogenic differentiation in murine marrow stromal cells. Bone. 2007, 40 (5): 1389-1398. 10.1016\/j.bone.2007.01.001.","journal-title":"Bone"},{"issue":"5","key":"1078_CR35","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1359\/jbmr.2001.16.5.876","volume":"16","author":"Y Yoshimura","year":"2001","unstructured":"Yoshimura Y, Nomura S, Kawasaki S, Tsutsumimoto T, Shimizu T, Takaoka K: Colocalization of noggin and bone morphogenetic protein-4 during fracture healing. J Bone Miner Res. 2001, 16 (5): 876-884. 10.1359\/jbmr.2001.16.5.876.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1078_CR36","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s00774-009-0068-4","volume":"27","author":"T Urano","year":"2009","unstructured":"Urano T, Shiraki M, Usui T, Sasaki N, Ouchi Y, Inoue S: Bone mass effects of a Smad6 gene polymorphism in Japanese postmenopausal women. J Bone Miner Metab. 2009, 27 (5): 562-566. 10.1007\/s00774-009-0068-4.","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"1078_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00223-001-2059-x","volume":"71","author":"J Justesen","year":"2001","unstructured":"Justesen J, Stenderup K, Eriksen EF, Kassem M: Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int. 2001, 71 (1): 36-44. 10.1007\/s00223-001-2059-x.","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"1078_CR38","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/jor.20623","volume":"26","author":"Y Jiang","year":"2008","unstructured":"Jiang Y, Mishima H, Sakai S, Liu YK, Ohyabu Y, Uemura T: Gene expression analysis of major lineage-defining factors in human bone marrow cells: Effect of aging, gender, and age-related disorders. J Orthop Res. 2008, 26 (7): 910-917. 10.1002\/jor.20623.","journal-title":"J Orthop Res"},{"issue":"11","key":"1078_CR39","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1158\/1055-9965.EPI-07-0449","volume":"16","author":"M Garcia-Closas","year":"2007","unstructured":"Garcia-Closas M, Troester MA, Qi Y, Langer\u00f8d A, Yeager M, Lissowska J, Brinton L, Welch R, Peplonska B, Gerhard DS, Gram IT, Kristensen V, B\u00f8rresen-Dale AL, Chanock S, Perou CM: Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status. Cancer Epidemiol Biomarkers Prev. 2007, 16 (11): 2269-2275. 10.1158\/1055-9965.EPI-07-0449.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6C","key":"1078_CR40","first-page":"4279","volume":"27","author":"S Vonlanthen","year":"2007","unstructured":"Vonlanthen S, Kawecki TJ, Betticher DC, Pfefferli M, Schwaller B: Heterozygosity of SNP513 in intron 9 of the human calretinin gene (CALB2) is a risk factor for colon cancer. Anticancer Res. 2007, 27 (6C): 4279-4288.","journal-title":"Anticancer Res"},{"issue":"12","key":"1078_CR41","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2106\/00004623-200212000-00001","volume":"84","author":"S Govender","year":"2002","unstructured":"Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, B\u00f6rner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, R\u00fcter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T, BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group: Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002, 84 (12): 2123-2134.","journal-title":"J Bone Joint Surg Am"},{"issue":"Suppl A","key":"1078_CR42","first-page":"151","volume":"83","author":"GE Friedlaender","year":"2001","unstructured":"Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S: Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001, 83 (Suppl A): 151-158.","journal-title":"J Bone Joint Surg Am"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-12-44.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-12-44\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-12-44","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-12-44.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T12:58:56Z","timestamp":1630501136000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-12-44"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,10]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1078"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-12-44","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,10]]},"assertion":[{"value":"17 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"44"}}